AtheroNova Inc. announced that Joan E. Shaw, MT (ASCP), SCC has joined the company as Senior Director of Clinical Operations. Between 2002 and 2012, she served in multiple areas of AstraZeneca ultimately serving as Executive Director of Clinical Operations in the Wilmington, Delaware headquarters. For the last two years, Ms. Shaw was the Executive Director of Continuous Improvement, leading a team of Master Black Belts to define efficiencies in the drug development process.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -26.67% |
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 9.69K | |
+25.83% | 47.96B | |
+45.38% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- AHROQ Stock
- News AtheroNova Inc.
- AtheroNova Inc. Names Joan E. Shaw as Senior Director of Clinical Operations